Antimicrobial resistance in European isolates of Pseudomonas aeruginosa

被引:36
作者
Fluit, AC [1 ]
Verhoef, J [1 ]
Schmitz, FJ [1 ]
机构
[1] Univ Utrecht, Med Ctr, Eijkman Winkler Inst, NL-3508 GA Utrecht, Netherlands
关键词
D O I
10.1007/s100960050497
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Pseudomonas aeruginosa is responsible for a substantial fraction of hospital infections. Twenty-Eve European university hospitals submitted a total of 1411 Pseudomonas aeruginosa isolates for susceptibility testing during 1997 and 1998. The isolates showed highest susceptibility to amikacin (87.5%), meropenem (87.3%) and piperacillin/tazobactam (86.8%). Susceptibility to ciprofloxacin was 73.2%. There was no clear geographical distribution of resistance, although isolates from northwestern Europe tended to be more susceptible than those from southeastern Europe. Isolates that were resistant to one class of antibiotics were also often resistant to at least one other class of antibiotics. Imipenem-resistant isolates were generally not clonally related.
引用
收藏
页码:370 / 374
页数:5
相关论文
共 14 条
[1]   β-lactamase-mediated resistance to extended spectrum cephalosporins among clinical isolates of Pseudomonas aeruginosa [J].
Ben-Mahrez, K ;
Rejiba, S ;
Belhadj, C ;
Belhadj, O .
RESEARCH IN MICROBIOLOGY, 1999, 150 (06) :403-406
[2]  
BERGOGNEBEREZIN E, 1999, INFECT DIS
[4]   OXA-16, a further extended-spectrum variant of OXA-10 β-lactamase, from two Pseudomonas aeruginosa isolates [J].
Danel, F ;
Hall, LMC ;
Gur, D ;
Livermore, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (12) :3117-3122
[5]  
Diekema DJ, 1999, CLIN INFECT DIS, V29, P595, DOI 10.1086/598640
[6]   Bacterial pathogens isolated from patients with skin and soft tissue infections: Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997) [J].
Doern, GV ;
Jones, RN ;
Pfaller, MA ;
Kugler, KC ;
Beach, ML .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 34 (01) :65-72
[7]   A 25-year study of nosocomial bacteremia in an adult intensive care unit [J].
Edgeworth, JD ;
Treacher, DF ;
Eykyn, SJ .
CRITICAL CARE MEDICINE, 1999, 27 (08) :1421-1428
[8]   Interplay between the efflux pump and the outer membrane permeability barrier in fluorescent dye accumulation in Pseudomonas aeruginosa [J].
Germ, M ;
Yoshihara, E ;
Yoneyama, H ;
Nakae, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (02) :452-455
[9]   Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa [J].
Lomovskaya, O ;
Lee, A ;
Hoshino, K ;
Ishida, H ;
Mistry, A ;
Warren, MS ;
Boyer, E ;
Chamberland, S ;
Lee, VJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) :1340-1346
[10]  
*NAT COMM CLIN LAB, 1998, STAND PERF STAND ANT